x

Search for a research project

* (*) mandatory field

Other search option(s)

46 Result(s)

Sort by

Funded by an IRDiRC member =

Research projects

AUSTRIA

STEIERMARK
GRAZ

The role of RKIP in myeloid leukemogenesis
Medizinische Universität Graz
Klinische Abteilung für Hämatologie

AUSTRIA

WIEN
WIEN

AUSTRIA

WIEN
WIEN

Functional interactions between EVI1 and atRA in LSCs (in acute myeloid leukemia)
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

BELGIUM

VLAAMS BRABANT
LEUVEN

The role of RAS- and RHO-GTPases, their regulators and mediators in the pathogenesis of myeloid malignancies.
University Hospitals Leuven - Gasthuisberg
Laboratory for Genetics of Malignant Disorders

CANADA

Ontario
HAMILTON

CANADA

Ontario
TORONTO

Funded by an IRDiRC memberCD123-Targeted Auger Electron Radioimmunotherapy of Acute Myelogenous Leukemia (AML)
University of Toronto
Leslie Dan Faculty of Pharmacy, University of Toronto

GERMANY

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

GERMANY

Baden-Württemberg
MANNHEIM

GERMANY

Baden-Württemberg
ULM

GERMANY

Baden-Württemberg
ULM

Characterising normal versus leukemic stem cells in patients with acute myeloic leukemia (German Cancer Aid)
Universitätsklinikum Ulm
Institut für Experimentelle Tumorforschung

GERMANY

Baden-Württemberg
ULM

Evaluation of Incidence and Prognostic Importance of Gene Mutations in acute myeloid leukemia (AML)
Universitätsklinikum Ulm am Oberen Eselsberg
Klinik für Innere Medizin III

GERMANY

Baden-Württemberg
ULM

Design and Evaluation of Real-Time RT-PCR Assays for the Detection of Minimal Residual Disease in AML
Universitätsklinikum Ulm am Oberen Eselsberg
Klinik für Innere Medizin III

GERMANY

Hessen
MARBURG

A synthetic lethal screen to identify novel targets for therapy in acute myeloid leukemia
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

GERMANY

Hessen
MARBURG

Epigenetics of the nuclear oncogene Ski in AML (SPP 1463: Epigenetic regulation of normal hematopoiesis and its dysregulation in myeloid neoplasia)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

GERMANY

Hessen
MARBURG

Cooperation of Ras induced signaling and the nuclear oncogene Ski in acute myeloid leukemia (AML) and malignant melanoma (TRR 17: Ras-dependent pathways in human cancer)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

GERMANY

Niedersachsen
HANNOVER

AML-BFM Registry 2012: Clinical registry for children and adolescents with acute myeloid leukemia
KPOH Geschäftsführung Hannover
Kompetenznetz Pädiatrische Onkologie und Hämatologie

GERMANY

Niedersachsen
HANNOVER

Signal transduction of c-Kit and c-Kit related tyrosine kinases: mRNA export and hematopoesis
Medizinische Hochschule Hannover
Institut für Physiologische Chemie

GERMANY

Niedersachsen
HANNOVER

The histamine H2-receptor as new target for differentiation therapy in acute myeloic leukemia
Medizinische Hochschule Hannover
Institut für Pharmakologie

GERMANY

Nordrhein-Westfalen
ESSEN

AML-BFM Registry 2012: Clinical registry for children and adolescents with acute myeloid leukemia
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

GERMANY

Sachsen
DRESDEN

AML Registry: Clinical AML Registry
Universitätsklinikum Carl Gustav Carus an der TU Dresden
SAL-Studienzentrale

SWEDEN

Stockholms läns landsting
STOCKHOLM

Study of chemotherapy resistance and DNA methylation in acute myeloid leukemia samples
Karolinska University Hospital - Huddinge
Hematology Centre

AUSTRIA

WIEN
WIEN

Funded by an IRDiRC memberENCCA: European Network for Cancer Research in Children and Adolescents - UK
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Funded by an IRDiRC memberENCCA: EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS - FR
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent

FRANCE

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

ITALY

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

EPOC: European paediatric oncology off-patent medicines consortium (coordination)
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

Multicentric Research projects